IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB)
CUSIP: 45674E109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 9,783,925
- Total 13F shares
- 286,664
- Share change
- -21,391,898
- Total reported value
- $599,128
- Price per share
- $2.09
- Number of holders
- 1
- Value change
- -$19,546,322
- Number of sells
- 28
Quarterly Holders Quick Answers
What is CUSIP 45674E109?
CUSIP 45674E109 identifies INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45674E109:
Top shareholders of INAB - IN8BIO, INC. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BIOS Capital Management, LP |
13F
|
Company |
88%
|
8,600,001
|
$1,427,600 | — | 31 Mar 2025 | |
| Aaron G.l. Fletcher |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
11,825,804
mixed-class rows
|
$1,289,996 | — | 02 May 2025 | |
| Leslie W. Kreis |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
11,825,804
mixed-class rows
|
$1,289,996 | — | 02 May 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
58%
|
5,696,202
|
$945,570 | — | 31 Mar 2025 | |
| William Tai-Wei Ho |
13D/G
|
— |
3.7%
|
151,223
|
$349,325 | $0 | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
13D/G
|
Company |
2.6%
from 13D/G
|
2,079,575
|
$345,209 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
18%
|
1,802,956
|
$299,291 | — | 31 Mar 2025 | |
| Transcend Partners Opportunity Fund I LLC |
13D/G
|
Transcend Partners Opportunity Fund LLC |
2.6%
|
107,416
|
$248,131 | $0 | 30 Jun 2025 | |
| AIGH Capital Management LLC |
13F
|
Company |
15%
|
1,450,000
|
$240,700 | — | 31 Mar 2025 | |
| Sigma Planning Corp |
13F
|
Company |
7.2%
|
700,680
|
$116,313 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
5.8%
|
568,631
|
$94,403 | — | 31 Mar 2025 | |
| Stonegate Investment Group, LLC |
13F
|
Company |
1.8%
|
180,000
|
$29,880 | — | 31 Mar 2025 | |
| Orin Hirschman |
13D/G
|
— |
4.4%
|
149,895
|
$17,987 | -$725,036 | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
93,420
|
$15,508 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.91%
|
88,746
|
$14,732 | — | 31 Mar 2025 | |
| XTX Topco Ltd |
13F
|
Company |
0.71%
|
69,708
|
$11,572 | — | 31 Mar 2025 | |
| Chicago Partners Investment Group LLC |
13F
|
Company |
0.71%
|
69,301
|
$11,400 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.6%
|
58,504
|
$9,712 | — | 31 Mar 2025 | |
| Trishna Goswami |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
440,925
mixed-class rows
|
$6,931 | — | 04 Sep 2024 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.35%
|
34,279
|
$5,690 | — | 31 Mar 2025 | |
| Overbrook Management Corp |
13F
|
Company |
0.35%
|
33,756
|
$5,604 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.3%
|
29,450
|
$4,889 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.25%
|
24,812
|
$4,119 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.21%
|
20,292
|
$3,368 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.15%
|
15,110
|
$3,000 | — | 31 Mar 2025 | |
| Capital Investment Advisory Services, LLC |
13F
|
Company |
0.18%
|
17,605
|
$2,922 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.13%
|
12,327
|
$2,046 | — | 31 Mar 2025 | |
| LPL Financial LLC |
13F
|
Company |
0.12%
|
11,350
|
$1,884 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.1%
|
10,000
|
$1,660 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0.08%
|
8,263
|
$1,372 | — | 31 Mar 2025 | |
| Westside Investment Management, Inc. |
13F
|
Company |
0.02%
|
2,000
|
$332 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0.01%
|
1,007
|
$167 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
485
|
$81 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
102
|
$17 | — | 31 Mar 2025 | |
| Travis Whitfill |
3/4/5
|
Director |
—
class O/S missing
|
42,676
|
— | — | 19 Dec 2024 |
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q2 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.